Logotype for DiaSorin S.p.A.

DiaSorin (DIA) investor relations material

DiaSorin Q3 2025 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for DiaSorin S.p.A.
Q3 2025 earnings summary5 Nov, 2025

Executive summary

  • Year-to-date revenues reached €900 million, up 3% year-over-year, with ex-COVID growth of 7% at constant exchange rates and core business (ex-COVID, constant FX) up 6%.

  • Adjusted EBITDA for 9M 2025 was €302 million, up 3% year-over-year (+7% at CER), with margin improving to 34%.

  • Immunodiagnostic strategy focused on expanding US hospital footprint, with 90 new hospitals added and a target of 600 by 2027.

  • Major commercial agreement signed with Quest Diagnostics for the LIAISON PLEX multiplexing molecular platform.

  • FDA 510(k) clearance received for Simplexa COVID-19, Flu A/B & RSV Direct test on the LIAISON MDX platform.

Financial highlights

  • Gross profit for the first nine months totaled €587 million (65% of revenues), up 2% year-over-year.

  • Adjusted EBIT reached €233 million (26% of revenues), in line with prior year.

  • Adjusted net income was €174 million (19% of revenues); net profit for 9M 2025 was €137 million, down 3% year-over-year.

  • Adjusted EBITDA margin for 9M 2025 was 34%; Q3 2025 margin was 32%, impacted by tariff changes and sales mix.

  • Net financial debt stood at €617 million, stable compared to December 2024.

  • Free cash flow reached €161 million, offset by €97 million in shareholder withdrawal payments and €63 million in dividends.

Outlook and guidance

  • Full-year 2025 guidance revised: ex-COVID revenue growth of ~5% at CER, COVID-related revenue at €10 million, and adjusted EBITDA margin at ~33%.

  • High single-digit top-line growth expected for 2026, with mid- to high-single-digit growth for Immuno and double-digit growth for Molecular in the medium term.

  • 2027 targets reaffirmed: high single- to low double-digit CAGR and 36–37% EBITDA margin.

  • Capital Market Day planned for Q2 2026 to update mid-term targets.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next DiaSorin earnings date

Logotype for DiaSorin S.p.A.
Q4 202513 Mar, 2026
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next DiaSorin earnings date

Logotype for DiaSorin S.p.A.
Q4 202513 Mar, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

DiaSorin S.p.A. develops and manufactures diagnostic tests and systems for use in clinical laboratories. The company provides immunodiagnostic and molecular diagnostic solutions for detecting infectious diseases, hormones, and oncology markers. It serves healthcare providers and laboratories worldwide. The company is headquartered in Saluggia, Italy, and its shares are listed on the BIT.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage